First Quadrant’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-400
| Closed | -$40K | – | 675 |
|
|
2020
Q3 | $40K | Sell |
400
-784
| -66% | -$86K | 0.01% | 504 |
|
|
2020
Q2 | $143K | Sell |
1,184
-516
| -30% | -$58.1K | 0.02% | 473 |
|
|
2020
Q1 | $161K | Hold |
1,700
| – | – | 0.02% | 405 |
|
|
2019
Q4 | $150K | Sell |
1,700
-4,600
| -73% | -$405K | 0.01% | 433 |
|
|
2019
Q3 | $502K | Hold |
6,300
| – | – | 0.05% | 309 |
|
|
2019
Q2 | $492K | Sell |
6,300
-957
| -13% | -$89.5K | 0.03% | 402 |
|
|
2019
Q1 | $852K | Buy |
7,257
+957
| +15% | +$112K | 0.07% | 285 |
|
|
2018
Q4 | $686K | Hold |
6,300
| – | – | 0.06% | 299 |
|
|
2018
Q3 | $806K | Hold |
6,300
| – | – | 0.02% | 415 |
|
|
2018
Q2 | $713K | Hold |
6,300
| – | – | 0.01% | 446 |
|
|
2018
Q1 | $708K | Hold |
6,300
| – | – | 0.01% | 438 |
|
|
2017
Q4 | $932K | Hold |
6,300
| – | – | 0.02% | 450 |
|
|
2017
Q3 | $738K | Sell |
6,300
-118,596
| -95% | -$15.1M | 0.01% | 494 |
|
|
2017
Q2 | $16.2M | Buy |
124,896
+16,569
| +15% | +$2.07M | 0.32% | 108 |
|
|
2017
Q1 | $14.7M | Sell |
108,327
-36,743
| -25% | -$5.57M | 0.29% | 136 |
|
|
2016
Q4 | $20.8M | Sell |
145,070
-13,186
| -8% | -$1.68M | 0.43% | 77 |
|
|
2016
Q3 | $18.7M | Buy |
158,256
+151,956
| +2,412% | +$18.3M | 0.4% | 79 |
|
|
2016
Q2 | $667K | Hold |
6,300
| – | – | 0.01% | 452 |
|
|
2016
Q1 | $702K | Sell |
6,300
-66,800
| -91% | -$8.45M | 0.02% | 450 |
|
|
2015
Q4 | $11.4M | Hold |
73,100
| – | – | 0.25% | 124 |
|
|
2015
Q3 | $9.6M | Sell |
73,100
-1,500
| -2% | -$241K | 0.21% | 137 |
|
|
2015
Q2 | $13M | Hold |
74,600
| – | – | 0.27% | 118 |
|
|
2015
Q1 | $12.9M | Sell |
74,600
-14,900
| -17% | -$2.27M | 0.27% | 115 |
|
|
2014
Q4 | $11.6M | Buy |
89,500
+74,600
| +501% | +$9.6M | 0.24% | 123 |
|
|
2014
Q3 | $1.92M | Sell |
14,900
-191,700
| -93% | -$19.8M | 0.04% | 298 |
|
|
2014
Q2 | $18.3M | Sell |
206,600
-44,200
| -18% | -$4.25M | 0.41% | 73 |
|
|
2014
Q1 | $23.6M | Sell |
250,800
-20,300
| -7% | -$2.08M | 0.54% | 53 |
|
|
2013
Q4 | $30.7M | Buy |
271,100
+56,000
| +26% | +$5.05M | 0.72% | 36 |
|
|
2013
Q3 | $17M | Buy |
215,100
+44,800
| +26% | +$3.27M | 0.43% | 75 |
|
|
2013
Q2 | $11.2M | Buy |
+170,300
| New | +$11M | 0.3% | 99 |
|
Other funds holding UTHR
First Quadrant's UTHR Position: Q4 2020 in Review
First Quadrant sold out of United Therapeutics (UTHR) in Q4 2020, closing a stake of 400 shares — an estimated $40K sold.
First Quadrant first reported a position in UTHR in Q2 2013 and held it in 30 quarters. The position peaked at $30.7M in Q4 2013. 356 funds tracked by Wall St. Rank hold UTHR as of Q4 2020.
- First Quadrant reported no remaining United Therapeutics position as of Q4 2020 after selling out during the quarter.
- First Quadrant sold 400 United Therapeutics shares in Q4 2020, an estimated $40K.
- First Quadrant first reported a position in United Therapeutics in Q2 2013 and held it in 30 quarters.
- First Quadrant's United Therapeutics position peaked at $30.7M in Q4 2013.
- 356 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2020.
Based on First Quadrant's 13F filing for Q4 2020, filed 27 Jan 2021.